Anticoagulant, adverse effect: Difference between revisions
Ttenbergen (talk | contribs) m Text replacement - "Anticoagulant drug, overdose/toxicity" to "Anticoagulant, overdose/toxicity" |
|||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 dx | |||
|ICD10 Code=Y44.2 | |||
|StartDate=2018-11-25 | |||
}} | |||
{{ICD10 category|Iatrogenic}} | |||
{{ICD10 category|Allergy}} | |||
{{ICD10 category|Adverse effect}} | |||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Other OD | | OldDxArticle =Other OD | ||
| Line 4: | Line 11: | ||
| InitialEditorAssigned = Not assigned | | InitialEditorAssigned = Not assigned | ||
}} | }} | ||
== Additional Info == | == Additional Info == | ||
Excludes: | |||
* [[Hemorrhage, due to anticoagulant or thrombolytic drug]] | |||
* [[Thrombolytic drug, adverse effect]] | |||
* [[Aspirin or other salicylate or NSAID, adverse effect]] | |||
* Adverse effects of other anti-platelet agents (e.g. clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brilinta)) | |||
*To code anti-platelet drugs see [[Drug or biological substance/agent NOS, adverse effect]] | |||
Includes: | Includes: | ||
* coumadin | * coumadin | ||
* heparin | * heparin -- i.e. "regular" (unfractionated) heparin | ||
* the low molecular weight heparins (LMWH): Enoxaparin, Dalteparin, Tinzaparin, Bemiparin, Nadroparin, Reviparin, Parnaparin, Certoparin, | |||
* the new oral anticoagulants (NOACs): apixaban (Eliquis), betrixaban (BevyxXa), dabigatran (Pradaxa), edoxaban (Savaysa) and rivaroxaban (Xarelto), and others will probably be created also | |||
If present also code | If present also code | ||